Management of elderly patients with a non-ST-segment-elevation acute coronary syndrome

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
M E Gimbel, J M Ten Berg

Abstract

Elderly patients with an acute coronary syndrome are underrepresented in randomised controlled trials. Neither the European Society of Cardiology nor the American Heart Association/American College of Cardiology acute coronary syndrome guidelines provide specific recommendations for elderly patients. However, elderly patients are at higher thrombotic and bleeding risk compared with younger patients leading to difficulties in choosing the optimal treatment. In this review, we discuss the uncertainties we encounter in treating elderly patients with non-ST-elevation acute coronary syndrome and suggest treatment options based on the existing literature.

References

Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Aug 25, 2001·Lancet·S R MehtaUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
Mar 16, 2006·The New England Journal of Medicine·UNKNOWN Fifth Organization to Assess Strategies in Acute Ischemic Syndromes InvestigatorsKeith A A Fox
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
May 22, 2009·The New England Journal of Medicine·Shamir R MehtaUNKNOWN TIMACS Investigators
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Sep 3, 2009·JAMA : the Journal of the American Medical Association·Gilles MontalescotUNKNOWN ABOARD Investigators
Jun 2, 2011·Journal of Clinical Pharmacology·Jeffrey S RiesmeyerWilliam L Macias
Sep 1, 2011·Circulation. Cardiovascular Quality and Outcomes·Mandeep SinghVeronique L Roger
Aug 28, 2012·The New England Journal of Medicine·Matthew T RoeUNKNOWN TRILOGY ACS Investigators
Sep 22, 2012·JACC. Cardiovascular Interventions·Stefano SavonittoUNKNOWN Italian Elderly ACS Trial Investigators
Sep 3, 2013·The New England Journal of Medicine·Gilles MontalescotUNKNOWN ACCOAST Investigators
May 28, 2014·Heart·Mauro Di BariUNKNOWN Acute Myocardial Infarction in Florence 2 (AMI Florence-2) Working Group
Aug 22, 2014·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Milosz JaguszewskiChristian Templin
Oct 15, 2014·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Ana FaustinoUNKNOWN researchers from the National Registry of Acute Coronary Syndromes, Portuguese Cardiology Society
Feb 28, 2015·Journal of the American College of Cardiology·Marco ValgimigliUNKNOWN ZEUS Investigators
Mar 17, 2015·The New England Journal of Medicine·Marc P BonacaUNKNOWN PEGASUS-TIMI 54 Steering Committee and Investigators
Oct 16, 2015·The New England Journal of Medicine·Philip UrbanUNKNOWN LEADERS FREE Investigators
Aug 12, 2016·International Journal of Cardiology·Gonzalo Luis Alonso SalinasJosé Luis Zamorano Gómez

❮ Previous
Next ❯

Citations

Mar 1, 2018·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·J J Piek
Aug 21, 2021·Journal of Transcultural Nursing : Official Journal of the Transcultural Nursing Society·Hsin-Yu ChaoEsther Ching-Lan Lin

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

CURE
PLATO

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.